David Taylor, M.D.
Medical Director for Drug Development, PATH
Dr. Taylor is board certified in Internal Medicine and Infectious Diseases and a Fellow of the Infectious Diseases Society of America (IDSA). Dr. Taylor’s expertise is in the design, conduct and analysis of clinical trials for development of products for the prevention and treatment of infectious diseases. He joined PATH in 2015 as a Senior Medical Officer in vaccine development, and began working full-time in drug development in 2017. His career is devoted to clinical research and product development. Dr. Taylor spent 20 years in government research — first at the Centers for Disease Control and then at the Walter Reed Army Institute of Research — and 10 years with the pharmaceutical and biotechnology industries in both drug and vaccine research and development. During his career, Dr. Taylor has worked on the fluoroquinolone antibiotics for gastroenterological and sexually transmitted diseases, rifaximin for traveler’s diarrhea, vaccines for the prevention of cholera, and other enteric infectious illnesses and influenza vaccines. Dr. Taylor received his M.D. degree from Harvard Medical School, his M.Sc. in Medical Parasitology from the London School of Tropical Medicine and Hygiene, and his ID fellowship at Johns Hopkins University. He has authored 176 peer reviewed papers and 25 review articles.